Home » Topics » BioWorld Science

BioWorld Science
RSS

New phase I study explores CYT-001 for adjuvant immunotherapy in hepatocellular carcinoma

March 20, 2018

First-in-human use of K1-70 shows value of blocking TSH-R for Graves' ophthalmopathy

March 20, 2018

Genentech reports data from phase III IMpower131 study of Tecentriq in NSCLC

March 20, 2018

Motif Bio revises timeline for iclaprim NDA submission

March 20, 2018

FDA grants priority review to Xtandi sNDA for nonmetastatic CRPC

March 20, 2018

PANORAMA trial of Eylea meets 24-week primary endpoint

March 20, 2018

MRTX-1519 identified as potent, orally available LSD1 inhibitor

March 20, 2018

Heron reports topline data from EPOCH1 and EPOCH2 phase III studies of HTX-011

March 20, 2018

PAT-DX1 demonstrates efficacy in animal model of glioblastoma

March 20, 2018

Expanded indication accepted in E.U. for Spiriva Respimat

March 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...